Grace Marianne Facio
Program Manager
Cancer Center
IRD 525
Health Sciences Campus
Los Angeles
Phase II study of gemcitabine and docetaxel in recurrent platinum resistant ovarian cancer Cancer Invest. 2012 May; 30(4):295-9. . View in PubMed
Phase I clinical trial of topotecan and pegylated liposomal doxorubicin Cancer Invest. 2005; 23(8):665-70. . View in PubMed
Phase II study of gemcitabine and weekly paclitaxel in recurrent platinum-resistant ovarian cancer Gynecol Oncol. 2004 May; 93(2):493-8. . View in PubMed
